This is a StreetInsider.com Premium Only Page

Innoviva (INVA) –

Apr 24, 2024 07:00 AM Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024

Mar 22, 2024 04:42 PM Form 10-K/A Innoviva, Inc. For: Dec 31

Mar 7, 2024 07:05 PM Form 4 Innoviva, Inc. For: Mar 05 Filed by: Basso Stephen

Mar 7, 2024 07:03 PM Form 4 Innoviva, Inc. For: Mar 05 Filed by: Ronsheim Matthew

Mar 7, 2024 07:00 PM Form 4 Innoviva, Inc. For: Mar 05 Filed by: Zhen Marianne

Mar 7, 2024 06:58 PM Form 4 Innoviva, Inc. For: Mar 05 Filed by: Raifeld Pavel

Mar 5, 2024 06:03 AM Form 10-K/A Innoviva, Inc. For: Dec 31

Mar 4, 2024 04:01 PM Armata Pharma (ARMP) Enters $35M Secured Credit Agreement with Innoviva (INVA)

Mar 4, 2024 04:01 PM Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva

Feb 29, 2024 05:03 PM Form 10-K Innoviva, Inc. For: Dec 31

Feb 29, 2024 04:17 PM Form 8-K Innoviva, Inc. For: Feb 29

Feb 29, 2024 04:05 PM Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress

Feb 22, 2024 09:31 PM Form 4 Innoviva, Inc. For: Feb 20 Filed by: Ronsheim Matthew

Feb 22, 2024 09:30 PM Form 4 Innoviva, Inc. For: Feb 20 Filed by: Zhen Marianne

Feb 14, 2024 07:24 AM Form SC 13G/A Innoviva, Inc. Filed by: PUTNAM INVESTMENTS LLC

Feb 13, 2024 05:11 PM Form SC 13G/A Innoviva, Inc. Filed by: VANGUARD GROUP INC

Feb 13, 2024 10:27 AM Form SC 13G/A Innoviva, Inc. Filed by: RENAISSANCE TECHNOLOGIES LLC

Feb 9, 2024 10:01 AM Form SC 13G Innoviva, Inc. Filed by: DIMENSIONAL FUND ADVISORS LP

Jan 22, 2024 09:17 PM Form 4 Innoviva, Inc. For: Jan 18 Filed by: Ronsheim Matthew

Jan 22, 2024 02:04 PM Form SC 13G/A Innoviva, Inc. Filed by: BlackRock Inc.

Jan 10, 2024 08:27 PM Form 3 Innoviva, Inc. For: Jan 01 Filed by: Ronsheim Matthew

Nov 22, 2023 04:30 PM Form 4 Innoviva, Inc. For: Nov 20 Filed by: Zhen Marianne

Nov 17, 2023 04:31 PM Form 4 Innoviva, Inc. For: Nov 15 Filed by: Zhen Marianne

Nov 13, 2023 04:12 PM Form S-8 Innoviva, Inc.

Nov 6, 2023 08:31 AM Form 8-K Innoviva, Inc. For: Nov 06

Nov 1, 2023 04:45 PM Form 10-Q Innoviva, Inc. For: Sep 30

Nov 1, 2023 04:31 PM Form 8-K Innoviva, Inc. For: Nov 01

Nov 1, 2023 04:29 PM Innoviva (INVA) Tops Q3 EPS by 71c

Nov 1, 2023 04:15 PM Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Nov 1, 2023 04:05 PM Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea

Oct 11, 2023 08:00 AM Innoviva Specialty Therapeutics Presents New Data on its Critical Care Antibiotic Therapy Portfolio at Infectious Disease Week (IDWeek) 2023

Sep 19, 2023 08:30 AM Innoviva to Participate in the Cantor Global Healthcare Conference

Sep 18, 2023 08:00 AM XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in

Aug 31, 2023 08:12 PM Form 4 Innoviva, Inc. For: Aug 31 Filed by: Basso Stephen

Aug 31, 2023 08:11 PM Form 3 Innoviva, Inc. For: Aug 21 Filed by: Basso Stephen

Aug 31, 2023 01:58 PM Form 4 Innoviva, Inc. For: Aug 18 Filed by: Zhen Marianne

Aug 25, 2023 05:25 PM Form 8-K Innoviva, Inc. For: Aug 21

Aug 25, 2023 05:00 PM Innoviva (INVA) Appoints Stephen Basso as CFO

Aug 25, 2023 04:52 PM Innoviva Appoints Stephen Basso as Chief Financial Officer

Aug 7, 2023 04:42 PM Form 8-K Innoviva, Inc. For: Aug 02

Aug 2, 2023 09:33 PM Form 4 Innoviva, Inc. For: Jul 31 Filed by: Koziel Margaret

Aug 2, 2023 09:32 PM Form 3 Innoviva, Inc. For: Jul 31 Filed by: Koziel Margaret

Aug 2, 2023 05:32 PM Innoviva (INVA) Misses Q2 EPS by 25c

Aug 2, 2023 05:03 PM Form 10-Q Innoviva, Inc. For: Jun 30

Aug 2, 2023 04:16 PM Form 8-K Innoviva, Inc. For: Aug 02

Aug 2, 2023 04:05 PM Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress

Jul 11, 2023 08:17 AM Form 8-K Innoviva, Inc. For: Jul 10

Jul 11, 2023 08:03 AM Armata Pharma (ARMP) Announces New Financing and Leadership Transition

Jul 11, 2023 08:00 AM Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics

Jun 21, 2023 04:40 PM Innoviva (INVA) 10% owner Denner buys another $800k in stock